Dow Up 0.36% Nasdaq Up 0.12%

Rexahn Pharmaceuticals, Inc. (RNN)

-NYSE MKT
0.70 0.01(1.26%) Aug 21, 4:00PM EDT
Prev Close:0.71
Open:0.72
Bid:0.69 x 10000
Ask:0.70 x 5000
1y Target Est:2.83
Beta:0.34
Next Earnings Date:N/A
Day's Range:0.69 - 0.72
52wk Range:0.36 - 1.85
Volume:363,815
Avg Vol (3m):1,172,400
Market Cap:124.60M
P/E (ttm):N/A
EPS (ttm):-0.16
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RNN

Comparison

Symbol% ChgMkt Cap
RNNDown 1.26%124.60M
GSK114.58B
PFE182.74B
RHHBY247.61B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.14
Quarterly EPS Est (Sep-14) :-0.02
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer. The company has three clinical stage oncology candidates: Archexin, RX-3117, and SupinoxinTM (RX-5902), as well as a pipel... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback